Apogee Therapeutics, Inc. (APGE) SEC Filings — 2024
29 SEC filings for Apogee Therapeutics, Inc. (APGE) in 2024.
Filings
- Apogee Therapeutics Files 8-K Corporate Update — 8-K · Dec 10, 2024
- Apogee Therapeutics Files 8-K Report — 8-K · Dec 2, 2024
- Apogee Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Apogee Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Apogee Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Apogee Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Apogee Therapeutics Files 8-K on Financials — 8-K · Nov 12, 2024
- Apogee Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Apogee Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Apogee Therapeutics Files 8-K — 8-K · Oct 24, 2024
- Apogee Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- Apogee Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 4, 2024
- Apogee Therapeutics Files 8-K Report — 8-K · Aug 19, 2024
- Apogee Therapeutics Files 8-K on Operations and Events — 8-K · Aug 12, 2024
- Apogee Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Apogee Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 7, 2024
- Apogee Therapeutics Proxy Statement Filed — DEFA14A · May 28, 2024
- Apogee Therapeutics Files 8-K — 8-K · May 15, 2024
- Apogee Therapeutics Files 8-K for Operations and Financials — 8-K · May 13, 2024
- Apogee Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Apogee Therapeutics Announces 2024 Annual Meeting of Stockholders on June 5 — DEF 14A · Apr 24, 2024
- Fairmount Funds Amends Apogee Therapeutics Stake — SC 13D/A · Apr 1, 2024
- Apogee Therapeutics Files 8-K — 8-K · Mar 25, 2024
- Apogee Therapeutics Files 8-K for Financials and Exhibits — 8-K · Mar 5, 2024
- Apogee Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
- Apogee Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Apogee Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- FMR LLC & Abigail Johnson Maintain 13.496% Stake in Apogee Therapeutics — SC 13G/A · Feb 9, 2024
- Fairmount Funds Amends Apogee Therapeutics Stake — SC 13D/A · Jan 31, 2024